SLP stock forecast
Our latest prediction for Simulations Plus, Inc.'s stock price was made on the April 20, 2018 when the stock price was at 17.85$.
In the short term (2weeks), SLP's stock price should underperform the market by -0.56%. During that period the price should oscillate between -5.52% and +5.06%.
In the medium term (3months), SLP's stock price should outperform the market by 0.37%. During that period the price should oscillate between -12.79% and +15.76%.Get email alerts
About Simulations Plus, Inc.
Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.
At the moment the company generates 36M USD in revenues.
On its last earning announcement, the company reported a profit of 0.50$ per share.
The book value per share is 1.79$
Three months stock forecastApril 20, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|